Development of candidate drugs for the treatment of Alzheimer's disease: I. investigation of metal chelators as inhibitors of the beta-amyloid aggregation; II. development of tacrine-ibuprofen hybrids
Development of candidate drugs for the treatment of Alzheimer's disease: I. investigation of metal chelators as inhibitors of the beta-amyloid aggregation; II. development of tacrine-ibuprofen hybrids